Forty Seven, Inc. (FTSV)
(Delayed Data from NSDQ)
$18.35 USD
+0.35 (1.94%)
Updated May 3, 2019 04:00 PM ET
After-Market: $18.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[FTSV]
Reports for Purchase
Showing records 21 - 40 ( 64 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Healthcare - Key Takeaways From Our KOL Event Series at ASH 2019
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Robust Data From MDS/AML Phase 1b Study; Higher PT $36; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Healthcare - ASH 2019: Don''t Miss Our KOL Event Series at ASH!
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Tipping The Phagocytic Balance May Drive A Successful Anti-Tumor Response
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Healthcare - ASH 2019: Meet the Doctors Who Will Speak at Our KOL Event Series
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
ASH 2019: Keep Your Eyes Peeled For These Presentations!
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Save The Date: KOL Events at ASH on December 9, 2019 in Orlando, FL
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Looking Ahead to ASH Results and 2020; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Q319 Chugging Along With Data Incoming At ASH And In 2020
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
5F9 Ready to Enter Pivotal Studies in MDS and DLBCL; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S